Literature DB >> 22118692

Histological features of nodular gastritis and its endoscopic classification.

Ryo Nakashima1, Naoyoshi Nagata, Kazuhiro Watanabe, Masao Kobayakawa, Toshiyuki Sakurai, Junichi Akiyama, Kazufusa Hoshimoto, Takuro Shimbo, Naomi Uemura.   

Abstract

OBJECTIVES: To clarify the histological features and endoscopic classifications of nodular gastritis (NG).
METHODS: Overall 40 996 patients who had undergone an upper gastrointestinal endoscopy were enrolled. NG is defined as a uniform and diffuse protrusion from the antrum to angulus, which has two types at endoscopy: nodular (N) and granular (G). Three biopsy specimens were taken from the antrum, angulus and corpus. The histological features were evaluated using the updated Sydney System (USS). The topography of gastritis (antrum-predominant, pangastritis or corpus-predominant) and the prevalence of lymphoid follicles were also investigated.
RESULTS: Overall 89 patients (0.22%) were diagnosed with NG, which tended to decrease in prevalence over age and predominantly affected women. All the patients were Helicobacter pylori-positive. Among these, 65 patients underwent biopsy. Activity and inflammation were mostly moderate or severe, while intestinal metaplasia and atrophy were mostly absent at all three sites. Pangastritis was the most frequent (72%) type of gastritis. Lymphoid follicles were found in 69% at the antrum, 65% at the angulus and 51% at the corpus. There were no significant differences between N and G types in clinical features, USS scores, topography of gastritis, and prevalence of lymphoid follicles.
CONCLUSIONS: Atrophy and intestinal metaplasia are rare but activity and chronic inflammation are severe at the antrum, angulus and corpus in NG. Pangastritis is the commonest type of gastritis. Lymphoid follicles affect everything up to the upper corpus, contrary to endoscopic protrusion found only at angulus. There was no correlation with pathological features between N and G types.
© 2011 The Authors. Journal of Digestive Diseases © 2011 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22118692     DOI: 10.1111/j.1751-2980.2011.00532.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  5 in total

1.  High Helicobacter pylori Bacterial Load and Low Cytokine Expression Levels Are Associated with Nodular Gastropathy.

Authors:  Rodrigo Mansilla-Vivar; Carolina A Serrano; Camila Palma; Macarena Vera; Caroll Hernandez; Margarita Pizarro; Javiera Torres; Paul R Harris; Eduardo Fuentes-López; Arnoldo Riquelme; Alberto Espino
Journal:  Dig Dis Sci       Date:  2019-08-07       Impact factor: 3.199

2.  Nodule Regression in Adults With Nodular Gastritis.

Authors:  Ji Wan Kim; Sun-Young Lee; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Chan-Sup Shim; Hye Seung Han
Journal:  Gastroenterology Res       Date:  2015-12-31

Review 3.  Helicobacter pylori chronic gastritis updated Sydney grading in relation to endoscopic findings and H. pylori IgG antibody: diagnostic methods.

Authors:  Taha M M Hassan; Samia I Al-Najjar; Ibrahim H Al-Zahrani; Fadi I B Alanazi; Malek G Alotibi
Journal:  J Microsc Ultrastruct       Date:  2016-03-24

4.  Clinical features of cardiac nodularity-like appearance induced by Helicobacter pylori infection.

Authors:  Toshihiro Nishizawa; Kosuke Sakitani; Hidekazu Suzuki; Shuntaro Yoshida; Yosuke Kataoka; Yousuke Nakai; Hirotoshi Ebinuma; Takanori Kanai; Osamu Toyoshima; Kazuhiko Koike
Journal:  World J Gastroenterol       Date:  2020-09-21       Impact factor: 5.742

5.  Consistency between the endoscopic Kyoto classification and pathological updated Sydney system for gastritis: A cross-sectional study.

Authors:  Osamu Toyoshima; Toshihiro Nishizawa; Shuntaro Yoshida; Tatsuya Matsuno; Nariaki Odawara; Akira Toyoshima; Kosuke Sakitani; Hidenobu Watanabe; Mitsuhiro Fujishiro; Hidekazu Suzuki
Journal:  J Gastroenterol Hepatol       Date:  2021-10-06       Impact factor: 4.369

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.